Form D · Other Health Care
NEPHROS INC
River Edge, NJ · CIK 1196298
Offering snapshot reported May 27, 2015 · SEC filing
- Reported sold
- $1.23M Offering amount: $1.5M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 12, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2015 | Initial | $1,228,982 | No comparison | 26 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-240641
Source: Form D, filed May 27, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Arthur Amron | Director |
| Lawrence Centella | Director |
| Daron Evans | Director, Executive |
| Paul Mieyal | Director |
| Malcolm Persen | Director |
| Matthew Rosenberg | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
41 Grand Avenue
River Edge, NJ, 07661
River Edge, NJ, 07661